The toxicity of dietary trans fats

Food and Chemical Toxicology

Volumn 78, Issue , 2015, Pages 170-176

  Ganguly, Riya ^a   Pierce, Grant N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Apoptosis; Atherosclerosis; Autophagy; Cardiovascular disease; Fatty acids; Heart

Indexed keywords

BECLIN 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLINOSITOL 3 KINASE; TRANS FATTY ACID; FAT INTAKE;

ACTION POTENTIAL; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOPHAGOSOME; AUTOPHAGY; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIETARY INTAKE; DNA FRAGMENTATION; FAT INTAKE; FATTY ACID OXIDATION; GENETIC PREDISPOSITION; GLYCOGEN SYNTHESIS; HEART MUSCLE; HEART PROTECTION; HUMAN; HYDROGENATION; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; LIFESTYLE; LIPID COMPOSITION; MEMBRANE FLUIDITY; MEMBRANE POTENTIAL; MEMBRANE STEADY POTENTIAL; NONHUMAN; PROTEIN DEGRADATION; REVIEW; RISK FACTOR; STRESS; ADVERSE EFFECTS; ANIMAL; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIET; PATHOPHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIET; DIETARY FATS; HUMANS; RISK FACTORS; TRANS FATTY ACIDS;

EID: 84923370169     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2015.02.004     Document Type: Review

References (64)

1. Ait-Oufella H., Taleb S., Mallat Z., Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler. Thromb. Vasc. Biol 2011, 31(5):969-979.
2. Akl H., Vervloessem T., Kiviluoto S., Bittremieux M., Parys J.B., De Smedt H., et al. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum. Biochim. Biophys. Acta 2014, 1843(10):2240-2252.
3. Alberts B., Wilson J.H., Hunt T. Molecular Biology of the Cell 2008, Garland Science., New York, 90 p. fifth ed.
4. Allison D.B., Egan S.K., Barraj L.M., Caughman C., Infante M., Heimbach J.T. Estimated intakes of trans fatty and other fatty acids in the US population. J. Am. Diet. Assoc 1999, 99(2):166-174.
5. Baer D.J., Judd J.T., Clevidence B.A., Tracy R.P. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am. J. Clin. Nutr 2004, 79(6):969-973.
6. Bassett C.M., McCullough R.S., Edel A.L., Maddaford T.G., Dibrov E., Blackwood D.P., et al. Trans-fatty acids in the diet stimulate atherosclerosis. Metabolism 2009, 58(12):1802-1808.
7. Bassett C.M., Edel A.L., Patenaude A.F., McCullough R.S., Blackwood D.P., Chouinard P.Y., et al. Dietary vaccenic acid has antiatherogenic effects in LDLr-/- mice. J. Nutr 2010, 140(1):18-24.
8. Bassett C.M., McCullough R.S., Edel A.L., Patenaude A., LaVallee R.K., Pierce G.N. The alpha-linolenic acid content of flaxseed can prevent the atherogenic effects of dietary trans fat. Am. J. Physiol. Heart Circ. Physiol 2011, 301(6):H2220-H2226.
9. Benesch M.G., Ko Y.M., McMullen T.P., Brindley D.N. Autotaxin in the crosshairs: taking aim at cancer and other inflammatory conditions. FEBS Lett 2014, 588(16):2712-2727.
10. Berne R.M., Koeppen B.M., Stanton B.A. Berne & Levy Physiology 2008, Mosby/Elsevier., Philadelphia, PA, xii, 836 p. sixth ed.
11. Blewett H.J., Gerdung C.A., Ruth M.R., Proctor S.D., Field C.J. Vaccenic acid favourably alters immune function in obese JCR:LA-cp rats. Br. J. Nutr 2009, 102(4):526-536.
12. Bryk D., Zapolska-Downar D., Malecki M., Hajdukiewicz K., Sitkiewicz D. Trans fatty acids induce a proinflammatory response in endothelial cells through ROS-dependent nuclear factor-kappaB activation. J. Physiol. Pharmacol 2011, 62(2):229-238.
13. Buja L.M. Myocardial ischemia and reperfusion injury. Cardiovasc. Pathol 2005, 14(4):170-175.
14. Camm A.J., Luscher T., Serruys P.W. The ESC Textbook of Cardiovascular Medicine 2009, Oxford University Press., Oxford; New York, 1398 p. second ed.
15. Cesen M.H., Pegan K., Spes A., Turk B. Lysosomal pathways to cell death and their therapeutic applications. Exp. Cell Res 2012, 318(11):1245-1251.
16. Cosentino K., Garcia-Saez A.J. Mitochondrial alterations in apoptosis. Chem. Phys. Lipids 2014, 181C:62-75.
17. Dashti N., Feng Q., Freeman M.R., Gandhi M., Franklin F.A. Trans polyunsaturated fatty acids have more adverse effects than saturated fatty acids on the concentration and composition of lipoproteins secreted by human hepatoma HepG2 cells. J. Nutr 2002, 132(9):2651-2659.
18. DeClercq V., Zahradka P., Taylor C.G. Dietary t10,c12-CLA but not c9,t11 CLA reduces adipocyte size in the absence of changes in the adipose renin-angiotensin system in fa/fa Zucker rats. Lipids 2010, 45(11):1025-1033.
19. Demel R.A., Jansen J.W., van Dijck P.W., van Deenen L.L. The preferential interaction of cholesterol with different classes of phospholipids. Biochim. Biophys. Acta 1977, 465(1):1-10.
20. Deniset J.F., Pierce G.N. The value of therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in cardiovascular disease. Fundam. Clin. Pharmacol 2010, 24:607-617.
21. Dupasquier C.M.C., Dibrov E., Kneesh A.L., Cheung P.K.M., Lee K.G.Y., Alexander H.K., et al. Dietary flaxseed inhibits atherosclerosis in the LDL receptor deficient mouse in part through anti-proliferative and anti-inflammatory actions. Am. J. Physiol 2007, 293:H2394-H2402.
22. Engelhard V.H., Esko J.D., Storm D.R., Glaser M. Modification of adenylate cyclase activity in LM cells by manipulation of the membrane phospholipid composition in vivo. Proc. Natl. Acad. Sci. U.S.A. 1976, 73(12):4482-4486.
23. Enig M.G., Atal S., Keeney M., Sampugna J. Isomeric trans fatty acids in the U.S. diet. J. Am. Coll. Nutr 1990, 9(5):471-486.
24. Feller S.E., Gawrisch K. Properties of docosahexaenoic-acid-containing lipids and their influence on the function of rhodopsin. Curr. Opin. Struct. Biol 2005, 15(4):416-422.
25. Field C.J., Blewett H.H., Proctor S., Vine D. Human health benefits of vaccenic acid. Appl. Physiol. Nutr. Metab 2009, 34(5):979-991.
26. Fulda S., Debatin K.M. Apoptosis signaling in tumor therapy. Ann. N. Y. Acad. Sci 2004, 1028:150-156.
27. Ganguly R., Lytwyn M.S., Pierce G.N. Differential effects of trans and polyunsaturated fatty acids on ischemia/reperfusion injury and its associated cardiovascular disease states. Curr. Pharm. Des 2013, 19(39):6858-6863.
28. Ghavami S., Cunnington R.H., Yeganeh B., Davies J.J., Rattan S.G., Bathe K., et al. Autophagy regulates trans fatty acid-mediated apoptosis in primary cardiac myofibroblasts. Biochim. Biophys. Acta 2012, 1823(12):2274-2286.
29. Ghobrial I.M., Witzig T.E., Adjei A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin 2005, 55:178-194.
30. Gottlieb R.A., Carreira R.S. Autophagy in health and disease. 5. Mitophagy as a way of life. Am. J. Physiol. Cell Physiol 2010, 299(2):C203-C210.
31. Hausenloy D.J., Yellon D.M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest 2013, 123(1):92-100.
32. Heart and Stroke Statistics H.a.S.F. Heart and Stroke Foundation http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.2796497/k.BF8B/Home.html.
33. Jaswal J.S., Keung W., Wang W., Ussher J.R., Lopaschuk G.D. Targeting fatty acid and carbohydrate oxidation - a novel therapeutic intervention in the ischemic and failing heart. Biochim. Biophys. Acta 2011, 1813(7):1333-1350.
34. Kapourchali F.R., Surendiran G., Chen L., Uitz E., Bahadori B., Moghadasian M.H. Animal models of atherosclerosis. World J. Clin. Cases 2014, 2(5):126-132.
35. Koga T., Nonaka M., Gu J.Y., Sugano M. Linoleic and alpha-linolenic acids differently modify the effects of elaidic acid on polyunsaturated fatty acid metabolism and some immune indices in rats. Br. J. Nutr 1997, 77(4):645-656.
36. Kummerow F.A., Zhou Q., Mahfouz M.M. Effect of trans fatty acids on calcium influx into human arterial endothelial cells. Am. J. Clin. Nutr 1999, 70(5):832-838.
37. Lee J.S., Kim Y.J., Kim C.L., Lee G.M. Differential induction of autophagy in caspase-3/7 down-regulating and Bcl-2 overexpressing recombinant CHO cells subjected to sodium butyrate treatment. J. Biotechnol 2012, 161(1):34-41.
38. Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature 2011, 469(7330):323-335.
39. Lin N.Y., Beyer C., Giessl A., Kireva T., Scholtysek C., Uderhardt S., et al. Autophagy regulates TNF alpha-mediated joint destruction in experimental arthritis. Ann. Rheum. Dis 2013, 72(5):761-768.
40. Lopez-Garcia E., Schulze M.B., Meigs J.B., Manson J.E., Rifai N., Stampfer M.J., et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr 2005, 135(3):562-566.
41. Ludke A., Sharma A.K., Bagchi A.K., Singal P.K. Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes. Mol. Cell. Biochem 2012, 360(1-2):215-224.
42. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol 1995, 146(1):3-15.
43. Maskrey B.H., Megson I.L., Whitfield P.D., Rossi A.G. Mechanisms of resolution of inflammation: a focus on cardiovascular disease. Arterioscler. Thromb. Vasc. Biol 2011, 31(5):1001-1006.
44. McCullough R.S., Edel A.L., Bassett C.M.C., LaVallee R.K., Dibrov E., Blackwood D.P., et al. The alpha linolenic acid content of flaxseed is associated with an induction of adipose leptin expression. Lipids 2011, 46:1043-1052.
45. Mitmesser S.H., Carr T.P. Trans fatty acids alter the lipid composition and size of apoB-100-containing lipoproteins secreted by HepG2 cells. J. Nutr. Biochem 2005, 16(3):178-183.
46. Mizushima N., Ohsumi Y., Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct. Funct 2002, 27(6):421-429.
47. Nihira K., Miki Y., Iida S., Narumi S., Ono K., Iwabuchi E., et al. An activation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosine kinase inhibitors in lung adenocarcinoma. J. Pathol 2014, 234(2):277-288.
48. Niu S.L., Mitchell D.C., Litman B.J. Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry 2005, 44(11):4458-4465.
49. Patel A.S., Lin L., Geyer A., Haspel J.A., An C.H., Cao J., et al. Autophagy in idiopathic pulmonary fibrosis. PLoS ONE 2012, 7(7). e41394.
50. Pierce G.N., Czubryt M.P. The contribution of ionic balance to ischemia/reperfusion-induced injury. J. Mol. Cell. Cardiol 1995, 27(1):53-63.
51. Poreba M., Strózyk A., Salvesen G.S., Drag M. Caspase substrates and inhibitors. Cold Spring Harb. Perspect. Biol 2013, 5(8). a008680.
52. Roach C., Feller S.E., Ward J.A., Shaikh S.R., Zerouga M., Stillwell W. Comparison of cis and trans fatty acid containing phosphatidylcholines on membrane properties. Biochemistry 2004, 43(20):6344-6351.
53. Saravanan N., Haseeb A., Ehtesham N.Z., Ghafoorunissa Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue. Eur. J. Endocrinol 2005, 153(1):159-165.
54. Siddiqui R.A., Harvey K.A., Ruzmetov N., Miller S.J., Zaloga G.P. n-3 fatty acids prevent whereas trans-fatty acids induce vascular inflammation and sudden cardiac death. Br. J. Nutr 2009, 102(12):1811-1819.
55. Tissier C., Vandroux D., Devillard L., Brochot A., Moreau D., Rochette L., et al. Substrate dependence of the postischemic cardiomyocyte recovery: dissociation between functional, metabolic and injury markers. Mol. Cell. Biochem 2005, 273(1-2):43-55.
56. Trump B.F., Berezesky I.K., Chang S.H., Phelps P.C. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol. Pathol 1997, 25(1):82-88.
57. van de Vijver L.P., Kardinaal A.F., Couet C., Aro A., Kafatos A., Steingrimsdottir L., et al. Association between trans fatty acid intake and cardiovascular risk factors in Europe: the TRANSFAIR study. Eur. J. Clin. Nutr 2000, 54(2):126-135.
58. Van Cruchten S., Van Den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat. Histol. Embryol 2002, 31(4):214-223.
59. Van Dijck P.W., De Kruijff B., Van Deenen L.L., De Gier J., Demel R.A. The preference of cholesterol for phosphatidylcholine in mixed phosphatidylcholine-phosphatidylethanolamine bilayers. Biochim. Biophys. Acta 1976, 455(2):576-587.
60. Vineis P., Wild C.P. Global cancer patterns: causes and prevention. Lancet 2014, 383(9916):549-557.
61. Wang Y., Jacome-Sosa M.M., Ruth M.R., Goruk S.D., Reaney M.J., Glimm D.R., et al. Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR:LA-cp rats. J. Nutr 2009, 139:2049-2054.
62. Wang Y., Jacome-Sosa M.M., Ruth M.R., Lu Y., Shen J., Reaney M.J., et al. The intestinal bioavailability of vaccenic acid and activation of peroxisome proliferator-activated receptor-alpha and -gamma in a rodent model of dyslipidemia and the metabolic syndrome. Mol. Nutr. Food Res 2012, 56(8):1234-1246.
63. World Health Organization Cardiovascular disease http://www.who.int/cardiovascular_diseases/en/.
64. Zardini P., Marino P., Golia G., Anselmi M., Castelli M. Ventricular remodeling and infarct expansion. Am. J. Cardiol 1993, 72(19):98G-106G.